216 related articles for article (PubMed ID: 36375042)
21. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW
Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333
[TBL] [Abstract][Full Text] [Related]
22. Current and evolving understanding of atypical chronic myeloid leukemia.
Schwartz LC; Mascarenhas J
Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
[TBL] [Abstract][Full Text] [Related]
23. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
[TBL] [Abstract][Full Text] [Related]
24. Atypical CML: diagnosis and treatment.
Breccia M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
[TBL] [Abstract][Full Text] [Related]
25. Chronic neutrophilic leukemia preceded by myelodysplastic syndromes.
Baba Y; Nakamaki T; Sakai H; Fukuchi K; Kabasawa N; Hattori N; Harada H
Int J Hematol; 2023 Nov; 118(5):636-641. PubMed ID: 37439996
[TBL] [Abstract][Full Text] [Related]
26. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
Freedman JL; Desai AV; Bailey LC; Aplenc R; Burnworth B; Zehentner BK; Teachey DT; Wertheim G
Pediatr Blood Cancer; 2016 Jan; 63(1):156-9. PubMed ID: 26274939
[TBL] [Abstract][Full Text] [Related]
27. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
Qian Y; Chen Y; Li X
Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
[TBL] [Abstract][Full Text] [Related]
28. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
[TBL] [Abstract][Full Text] [Related]
29. Atypical chronic myeloid leukaemia with trisomy 13: a case report.
Guo-yu H; Chao-hui Y; Kui T; Zhen-zhen C
Chin Med Sci J; 2011 Dec; 26(4):254-6. PubMed ID: 22218057
[TBL] [Abstract][Full Text] [Related]
30. Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.
Gao J; Han S; Deng B; Deng Y; Gao X
Ann Hematol; 2023 Nov; ():. PubMed ID: 37993585
[TBL] [Abstract][Full Text] [Related]
31. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.
Drexler HG; Nagel S; Quentmeier H
Curr Oncol; 2021 May; 28(3):1790-1794. PubMed ID: 34068566
[TBL] [Abstract][Full Text] [Related]
32. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract][Full Text] [Related]
33. The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.
Elliott MA; Tefferi A
Curr Opin Hematol; 2014 Mar; 21(2):148-54. PubMed ID: 24335708
[TBL] [Abstract][Full Text] [Related]
34. Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia.
Khanna V; Pierce ST; Dao KH; Tognon CE; Hunt DE; Junio B; Tyner JW; Druker BJ
Cureus; 2015 Dec; 7(12):e414. PubMed ID: 26870618
[TBL] [Abstract][Full Text] [Related]
35. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S
Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959
[TBL] [Abstract][Full Text] [Related]
36. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
[TBL] [Abstract][Full Text] [Related]
37. Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.
Zhang H; Wilmot B; Bottomly D; Dao KT; Stevens E; Eide CA; Khanna V; Rofelty A; Savage S; Reister Schultz A; Long N; White L; Carlos A; Henson R; Lin C; Searles R; Collins RH; DeAngelo DJ; Deininger MW; Dunn T; Hein T; Luskin MR; Medeiros BC; Oh ST; Pollyea DA; Steensma DP; Stone RM; Druker BJ; McWeeney SK; Maxson JE; Gotlib JR; Tyner JW
Blood; 2019 Sep; 134(11):867-879. PubMed ID: 31366621
[TBL] [Abstract][Full Text] [Related]
38. Chronic neutrophilic leukemia complicated with monoclonal gammopathy of undetermined significance: A case report and literature review.
Gao JP; Zhai LJ; Gao XH; Min FL
J Clin Lab Anal; 2022 Apr; 36(4):e24287. PubMed ID: 35170077
[TBL] [Abstract][Full Text] [Related]
39. Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management.
Elliott MA; Tefferi A
Am J Hematol; 2014 Jun; 89(6):651-8. PubMed ID: 24845374
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
Ouyang Y; Qiao C; Chen Y; Zhang SJ
Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
